Pliant Therapeutics (PLRX) Assets (2019 - 2026)
Pliant Therapeutics (PLRX) posted quarterly Assets of $202.6 million for Q1 2026, down 41.24% year-over-year from $344.8 million in Q1 2025, and down 10.05% quarter-over-quarter from $225.2 million in Q4 2025.
Pliant Therapeutics (PLRX) Assets (2019 - 2026) Analysis & Trends
Pliant Therapeutics (PLRX) has reported Assets for 8 consecutive years, with $202.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets fell 41.24% year-over-year to $202.6 million; the TTM figure through Mar 2026 stood at $202.6 million (down 41.24% YoY), while the FY2025 annual figure was $225.2 million, down 43.26% from the prior year.
- Assets slipped to $202.6 million in Q1 2026 per PLRX's latest filing, from $225.2 million in the prior quarter.
- Across five years, Assets topped out at $597.9 million in Q1 2023 and bottomed at $184.6 million in Q2 2022.
- Historically, Assets has averaged $384.2 million across 5 years, with a median of $377.2 million in 2022.
- Annual changes were most pronounced in 2023 — Assets jumped 211.39% — and 2025, when it slumped 43.26%.
- Pliant Therapeutics' Assets stood at $350.6 million in 2022, then soared by 46.07% to $512.2 million in 2023, then retreated by 22.49% to $396.9 million in 2024, then plunged by 43.26% to $225.2 million in 2025, then fell by 10.05% to $202.6 million in 2026.
- Business Quant data shows PLRX's Assets at $202.6 million in Q1 2026, $225.2 million in Q4 2025, and $276.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Pliant Therapeutics | 70.59 Mn | 70.59 Mn | - | 189.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 189.88 Mn |
| Mar 31, 2026 | 202.60 Mn |
| Dec 31, 2025 | 225.23 Mn |
| Sep 30, 2025 | 276.60 Mn |
| Jun 30, 2025 | 299.82 Mn |
| Mar 31, 2025 | 344.77 Mn |
| Dec 31, 2024 | 396.95 Mn |
| Sep 30, 2024 | 445.67 Mn |
| Jun 30, 2024 | 483.73 Mn |
| Mar 31, 2024 | 521.61 Mn |
| Dec 31, 2023 | 512.15 Mn |
| Sep 30, 2023 | 540.46 Mn |
| Jun 30, 2023 | 574.89 Mn |
| Mar 31, 2023 | 597.88 Mn |
| Dec 31, 2022 | 350.61 Mn |
| Sep 30, 2022 | 377.18 Mn |
| Jun 30, 2022 | 184.62 Mn |
| Mar 31, 2022 | 197.02 Mn |
| Dec 31, 2021 | 221.22 Mn |
| Sep 30, 2021 | 234.12 Mn |